ELAN - Elanco Animal Health Inc

Insider Purchase by Simmons Jeffrey N (Pres, CEO, Dir)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

2 months ago, Simmons Jeffrey N, serving as Pres, CEO, Dir at Elanco Animal Health Inc (ELAN), purchased 22,000 shares at $21.75 per share, for a total transaction value of $478,496.00. Following this transaction, Simmons Jeffrey N now holds 1,969,380 shares of ELAN.

This purchase represents a 1.00% increase in Simmons Jeffrey N's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, December 11, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 15, 2025, 4 days after the trade was made.

Elanco Animal Health Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Simmons Jeffrey N

Simmons Jeffrey N

Pres, CEO, Dir

Jeffrey N. Simmons is the President, Chief Executive Officer, and Director of Elanco Animal Health Inc. (NYSE: ELAN), a leading global animal health company focused on innovation in food and companionship enriching life.[[1]](https://edgementoring.org/our-board/)[[2]](https://www.mckinsey.com/industries/life-sciences/our-insights/spurring-innovation-in-animal-health-an-interview-with-elancos-jeff-simmons)[[3]](https://elanco.com/us/leadership) He has served in this role since at least 2008 as President of Elanco, initially as the animal health division of Eli Lilly and Company, where he also held positions as Senior Vice President and Executive Officer, and led the company's spin-off as an independent public entity in 2019.[[1]](https://edgementoring.org/our-board/)[[2]](https://www.mckinsey.com/industries/life-sciences/our-insights/spurring-innovation-in-animal-health-an-interview-with-elancos-jeff-simmons)[[3]](https://elanco.com/us/leadership) Simmons brings over three decades of experience at Elanco, starting from sales, marketing, and management roles in the U.S. and internationally, which shaped his commitment to global food security solutions.[[1]](https://edgementoring.org/our-board/)[[2]](https://www.mckinsey.com/industries/life-sciences/our-insights/spurring-innovation-in-animal-health-an-interview-with-elancos-jeff-simmons) Raised on a dairy farm, he has driven key acquisitions like Janssen Animal Health (2011) and Novartis Animal Health (2014), advanced innovations such as needle-free treatments and parvovirus therapies, and founded initiatives like Hatch for Hunger to combat food insecurity, nearing 100 million meals distributed.[[2]](https://www.mckinsey.com/industries/life-sciences/our-insights/spurring-innovation-in-animal-health-an-interview-with-elancos-jeff-simmons)[[6]](https://www.businessinsider.com/career-advice-elanco-ceo-shares-with-six-kids-2025-12) He also founded and chairs EDGE Mentoring and emphasizes cultural integration and persistent innovation in the animal health industry.[[1]](https://edgementoring.org/our-board/)[[6]](https://www.businessinsider.com/career-advice-elanco-ceo-shares-with-six-kids-2025-12)

View full insider profile →

Trade Price

$21.75

Quantity

22,000

Total Value

$478,496.00

Shares Owned

1,969,380

Trade Date

Thursday, December 11, 2025

73 days ago

SEC Filing Date

Monday, December 15, 2025

Filed 4 days after trade

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About Elanco Animal Health Inc

Company Overview

No company information available
View news mentioning ELAN

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/2255076

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime